Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emine Hatipoglu

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
JRSM Cardiovascular Disease|November 1, 2013
Catheter-based renal denervation for treatment of resistant hypertensionEmine Hatipoglu, Albert Ferro
Melanoma Management|September 8, 2018
Pembrolizumab in the management of metastatic melanomaLavinia Spain, Eugenie Younger, Emine Hatipoglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2025
Letetresgene Autoleucel: A Milestone in Treatment of Myxoid/Round Cell LiposarcomaEmine Hatipoglu, Andrew J S Furness, Robin L Jones
Current Oncology Reports|August 14, 2025
Adoptive T-Cell Therapy in SarcomasMonika Kucharczyk, Emine Hatipoglu, Robin L Jones, et al.
Indian Journal of Surgical Oncology|December 19, 2025
A Comprehensive Review of Chemotherapy in Localized Soft Tissue Sarcomas: Is the Cat Out of the Bag Yet?Anand Mohan, Abhay K Kattepur, Shraddha Patkar, et al.
Cancer Cell|October 22, 2011
Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signalingJulie Adam, Emine Hatipoglu, Linda O'Flaherty, et al.
Lancet (London, England)|July 1, 2021
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOCEmma C Wall, Mary Wu, Ruth Harvey, et al.
Lancet (London, England)|June 6, 2021
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccinationEmma C Wall, Mary Wu, Ruth Harvey, et al.
Lancet (London, England)|January 22, 2022
Three-dose vaccination elicits neutralising antibodies against omicronMary Wu, Emma C Wall, Edward J Carr, et al.
The Journal of Pathology|June 2, 2011
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation statusChiara Bardella, Mona El-Bahrawy, Norma Frizzell, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
JRSM Cardiovascular Disease|November 1, 2013
Catheter-based renal denervation for treatment of resistant hypertensionEmine Hatipoglu, Albert Ferro
Melanoma Management|September 8, 2018
Pembrolizumab in the management of metastatic melanomaLavinia Spain, Eugenie Younger, Emine Hatipoglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2025
Letetresgene Autoleucel: A Milestone in Treatment of Myxoid/Round Cell LiposarcomaEmine Hatipoglu, Andrew J S Furness, Robin L Jones
Current Oncology Reports|August 14, 2025
Adoptive T-Cell Therapy in SarcomasMonika Kucharczyk, Emine Hatipoglu, Robin L Jones, et al.
Indian Journal of Surgical Oncology|December 19, 2025
A Comprehensive Review of Chemotherapy in Localized Soft Tissue Sarcomas: Is the Cat Out of the Bag Yet?Anand Mohan, Abhay K Kattepur, Shraddha Patkar, et al.
Cancer Cell|October 22, 2011
Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signalingJulie Adam, Emine Hatipoglu, Linda O'Flaherty, et al.
Lancet (London, England)|July 1, 2021
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOCEmma C Wall, Mary Wu, Ruth Harvey, et al.
Lancet (London, England)|June 6, 2021
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccinationEmma C Wall, Mary Wu, Ruth Harvey, et al.
Lancet (London, England)|January 22, 2022
Three-dose vaccination elicits neutralising antibodies against omicronMary Wu, Emma C Wall, Edward J Carr, et al.
The Journal of Pathology|June 2, 2011
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation statusChiara Bardella, Mona El-Bahrawy, Norma Frizzell, et al.
Pageof 2